Follow
Swapnil Mishra
Title
Cited by
Cited by
Year
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ...
Nature 584 (7820), 257-261, 2020
3031*2020
The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries
PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ...
Science 369 (6502), 413-422, 2020
1164*2020
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England
E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ...
Nature 593 (7858), 266-269, 2021
1147*2021
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil
NR Faria, TA Mellan, C Whittaker, IM Claro, DS Candido, S Mishra, ...
Science 372 (6544), 815-821, 2021
9222021
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’
E Lavezzo, E Franchin, C Ciavarella, G Cuomo-Dannenburg, L Barzon, ...
Nature 584 (7821), 425-429, 2020
8352020
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ...
Nature 599 (7883), 114-119, 2021
692*2021
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ...
The Lancet Global Health 8 (9), e1132-e1141, 2020
520*2020
Evolution and epidemic spread of SARS-CoV-2 in Brazil
DS Candido, IM Claro, JG De Jesus, WM Souza, FRR Moreira, ...
Science 369 (6508), 1255-1260, 2020
462*2020
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study
NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ...
The Lancet Infectious Diseases 20 (12), 1381-1389, 2020
185*2020
Age groups that sustain resurging COVID-19 epidemics in the United States
M Monod, A Blenkinsop, X Xi, D Hebert, S Bershan, S Tietze, M Baguelin, ...
Science 371 (6536), eabe8372, 2021
1672021
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ...
Science 374 (6570), 995-999, 2021
1592021
Feature driven and point process approaches for popularity prediction
S Mishra, MA Rizoiu, L Xie
Proceedings of the 25th ACM international on conference on information and …, 2016
1522016
Subnational analysis of the COVID-19 epidemic in Brazil
TA Mellan, HH Hoeltgebaum, S Mishra, C Whittaker, RP Schnekenberg, ...
MedRxiv, 2020
132*2020
State-level tracking of COVID-19 in the United States
HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ...
Nature communications 11 (1), 1-9, 2020
1282020
A tutorial on hawkes processes for events in social media
MA Rizoiu, Y Lee, S Mishra, L Xie
arXiv preprint arXiv:1708.06401, 2017
123*2017
Response to COVID-19 in South Korea and implications for lifting stringent interventions
A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ...
BMC medicine 18 (1), 1-12, 2020
1122020
SIR-Hawkes: linking epidemic models and Hawkes processes to model diffusions in finite populations
MA Rizoiu, S Mishra, Q Kong, M Carman, L Xie
Proceedings of the 2018 world wide web conference, 419-428, 2018
105*2018
Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus
NR Faria, TA Mellan, C Whittaker, IM Claro, DDS Candido, S Mishra, ...
Brazil. medRxiv 2021 (26.21252554), 2021
972021
Have deaths from COVID-19 in Europe plateaued due to herd immunity?
LC Okell, R Verity, OJ Watson, S Mishra, P Walker, C Whittaker, ...
The Lancet 395 (10241), e110-e111, 2020
882020
Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling
NF Brazeau, R Verity, S Jenks, H Fu, C Whittaker, P Winskill, I Dorigatti, ...
Communications medicine 2 (1), 1-13, 2022
84*2022
The system can't perform the operation now. Try again later.
Articles 1–20